2012-10-06 19:23:27 - Recently published research from Global Markets Direct, "Resolvyx Pharmaceuticals, Inc - Product Pipeline Review - 2012", is now available at Fast Market Research

Global Market Direct's pharmaceuticals report, "Resolvyx Pharmaceuticals, Inc - Product Pipeline Review - 2012" provides data on the Resolvyx Pharmaceuticals, Inc's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Resolvyx Pharmaceuticals, Inc's corporate website, SEC filings, investor presentations and featured press releases, both from Resolvyx Pharmaceuticals, Inc and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Resolvyx Pharmaceuticals, Inc - Brief Resolvyx Pharmaceuticals, Inc overview including business description, key information and facts, and its locations and subsidiaries.
* Review of

current pipeline of Resolvyx Pharmaceuticals, Inc human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Resolvyx Pharmaceuticals, Inc with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Resolvyx Pharmaceuticals, Inc's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468597_resolvyx_pharmaceuticals_inc_product_ ..


Reasons to buy

* Evaluate Resolvyx Pharmaceuticals, Inc's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Resolvyx Pharmaceuticals, Inc in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Resolvyx Pharmaceuticals, Inc's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Resolvyx Pharmaceuticals, Inc.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Resolvyx Pharmaceuticals, Inc and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Resolvyx Pharmaceuticals, Inc Snapshot
Resolvyx Pharmaceuticals, Inc Overview
Key Information
Key Facts
Resolvyx Pharmaceuticals, Inc - Research and Development Overview
Key Therapeutic Areas
Resolvyx Pharmaceuticals, Inc - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Resolvyx Pharmaceuticals, Inc - Pipeline Products Glance
Resolvyx Pharmaceuticals, Inc - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Resolvyx Pharmaceuticals, Inc - Drug Profiles
Resolvin Analogs
Product Description
Mechanism of Action
R&D Progress
RX-10001
Product Description
Mechanism of Action
R&D Progress
RX-10008
Product Description
Mechanism of Action
R&D Progress
RX-20001
Product Description
Mechanism of Action
R&D Progress
Resolvyx Pharmaceuticals, Inc - Pipeline Products by Route of Administration
Resolvyx Pharmaceuticals, Inc - Pipeline Products By Mechanism of Action
Resolvyx Pharmaceuticals, Inc - Dormant Projects
Resolvyx Pharmaceuticals, Inc - Locations And Subsidiaries
Head Office
Financial Deals Landscape
Resolvyx Pharmaceuticals, Inc, Deals Summary
Resolvyx Pharmaceuticals, Inc, Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Resolvyx Pharma Raises $1.2 Million In Venture Financing
Resolvyx Pharma Secures $25 Million In Series B Financing
Partnerships
National Neurovision Research Institute Enters Into Co-Development Agreement With Resolvyx Pharma
Licensing Agreements
Celtic Therapeutics Enters Into Licensing Agreement With Resolvyx Pharma For RX-10045
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Resolvyx Pharmaceuticals, Inc, Key Information
Resolvyx Pharmaceuticals, Inc, Key Facts
Resolvyx Pharmaceuticals, Inc - Pipeline by Indication, 2012
Resolvyx Pharmaceuticals, Inc - Pipeline by Stage of Development, 2012
Resolvyx Pharmaceuticals, Inc - Monotherapy Products in Pipeline, 2012
Resolvyx Pharmaceuticals, Inc - Pre-Clinical, 2012
Resolvyx Pharmaceuticals, Inc - Discovery, 2012
Resolvyx Pharmaceuticals, Inc - Pipeline By Route of Administration, 2012
Resolvyx Pharmaceuticals, Inc - Pipeline Products By Mechanism of Action, 2012
Resolvyx Pharmaceuticals, Inc - Dormant Developmental Projects,2012
Resolvyx Pharmaceuticals, Inc, Deals Summary
Resolvyx Pharma Raises $1.2 Million In Venture Financing
Resolvyx Pharma Secures $25 Million In Series B Financing
National Neurovision Research Institute Enters Into Co-Development Agreement With Resolvyx Pharma
Celtic Therapeutics Enters Into Licensing Agreement With Resolvyx Pharma For RX-10045

List of Figures
Resolvyx Pharmaceuticals, Inc - Pipeline by Indication, 2012
Resolvyx Pharmaceuticals, Inc - Pipeline by Stage of Development, 2012
Resolvyx Pharmaceuticals, Inc - Monotherapy Products in Pipeline, 2012
Resolvyx Pharmaceuticals, Inc - Pipeline By Route of Administration, 2012

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468597&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.